Across TCGA pan-cancer cohorts, GRK6 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of GRK6’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where GRK6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GRK6 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.
KIRC, KIRP, and COAD are the cancer types where GRK6 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GRK6 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.